These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30039258)

  • 1. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
    Petrillo A; Fusco R; Petrillo M; Granata V; Bianco F; Di Marzo M; Delrio P; Tatangelo F; Botti G; Pecori B; Avallone A
    Jpn J Radiol; 2018 Oct; 36(10):611-621. PubMed ID: 30039258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
    Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
    Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC.
    Petrillo A; Fusco R; Petrillo M; Granata V; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Ciliberto G
    Eur Radiol; 2015 Jul; 25(7):1935-45. PubMed ID: 25577525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the standardized index of shape tool to analyze DCE-MRI data in the assessment of neo-adjuvant therapy in locally advanced rectal cancer.
    Fusco R; Granata V; Sansone M; Rega D; Delrio P; Tatangelo F; Romano C; Avallone A; Pupo D; Giordano M; Grassi R; Ravo V; Pecori B; Petrillo A
    Radiol Med; 2021 Aug; 126(8):1044-1054. PubMed ID: 34041663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
    Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
    Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
    Zou HH; Yu J; Wei Y; Wu JF; Xu Q
    J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
    Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
    Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR Imaging with Apparent Diffusion Coefficient Histogram Analysis: Evaluation of Locally Advanced Rectal Cancer after Chemotherapy and Radiation Therapy.
    Enkhbaatar NE; Inoue S; Yamamuro H; Kawada S; Miyaoka M; Nakamura N; Sadahiro S; Imai Y
    Radiology; 2018 Jul; 288(1):129-137. PubMed ID: 29558294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
    Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
    Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R
    Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of perfusion parameters from golden-angle radial sparse parallel dynamic contrast-enhanced magnetic resonance imaging in predicting pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Pan YN; Gu MY; Mao QL; Wei YG; Zhang L; Tang GY
    Diagn Interv Radiol; 2024 Jul; 30(4):228-235. PubMed ID: 38528760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
    Intven M; Monninkhof EM; Reerink O; Philippens ME
    Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.
    Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY
    Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
    J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
    Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of state-of-the-art rectal MRI sequences for the diagnosis of extramural vascular invasion in locally advanced rectal cancer after preoperative chemoradiotherapy: dos or maybes?
    Crimì F; Angelone R; Corso A; Bao QR; Cabrelle G; Vernuccio F; Spolverato G; Pucciarelli S; Quaia E
    Eur Radiol; 2023 Oct; 33(10):6852-6860. PubMed ID: 37115215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.